Program

Sunday, 21 Feb 2027 10:00 a.m.–5:00 p.m.

Soterix Medical

Advanced Neuromodulation and Neuromonitoring Training Workshop with Updates on the Latest Technologies The workshop will focus on fundamentals and advanced applications of non-invasive neuromodulation and neuromonitoring technologies, with in-depth product demonstrations and hands-on training. Topics include: - Conventional and High Definition transcranial Electrical Stimulation (tES/HD-tES)

- Remote Supervised tDCS/tES and HD-tES

- Our first hybrid HD-tES and EEG solution (MXN-GO EEG)

- Temporal Interference (TI) / Interferential Stimulation (IFS)

- Repetitive transcranial Magnetic Stimulation (rTMS) with Soterix Medical SPRY TMS and Neuronavigation

- Transcranial-focused Ultrasound Stimulation (tFUS)

- Galvanic Vestibular Stimulation (GVS), transcutaneous Auricular Vagus Nerve

- Stimulation (taVNS), and closed-loop transcranial Electrical Stimulation (tES) and monitoring

- New and upcoming technologies

Register hereopens in new tab/window

Sunday, 21 Feb 2027 Morning session from 10:00 to 13:00 – Free

MagVenture

Theme: Next wave of convulsive therapy using MagVenture MST Technology Join leading experts and early pioneers in Magnetic Seizure Therapy (MST) for a unique full-day educational and training experience. The two workshops have been intentionally designed as a connected program, with the morning session providing the clinical and scientific foundation that naturally flows into the hands-on certification workshop in the afternoon. We strongly encourage participants to attend both sessions to gain the full educational and practical MST experience. Attend the full-day MST experience: Learn the science in the morning. Gain certification and practical expertise in the afternoon. Education in MST — the next wave of convulsive therapy using Non-invasive Electromagnetic Ultra Rapid Onset Neuromodulation Therapy. This educational session will explore the science, clinical evidence, and future potential of Magnetic Seizure Therapy (MST), an emerging next-generation convulsive therapy platform. Register hereopens in new tab/window

Sunday, 21 Feb 2027 Afternoon Session from 14:00 to 17:00 - Registration fee 399€

MagVenture

MST Early Pioneer Training & Technology Certification - hands on session Building directly on the concepts covered during the morning session, the afternoon workshop provides an immersive training experience for clinicians and researchers interested in becoming early adopters of MST technology. Register hereopens in new tab/window

Sunday, 21 Feb 2027 2:00–5:00 p.m.

BRAINBOX

Practical Introduction to Transcranial Ultrasound Stimulation

Join Brainbox & The Brainbox Initiative for a Sunday afternoon workshop designed to provide attendees with an in-depth understanding of TUS techniques and their applications in non-invasive brain stimulation research. Led by esteemed experts in the field, who will provide attendees with valuable information and insights that they can take back to their own research.

Topics covered:

- Fundamentals of transcranial ultrasound stimulation (TUS) as a non-invasive brain stimulation technique

- Research applications and uses of TUS

- Demonstrations of TUS equipment

- Advanced computational modelling techniques for focused ultrasound

Register hereopens in new tab/window

Monday, 22 Feb 2027 7:30–8:30 a.m.

MagVenture

Next-gen TMS Technology — Personalization, Accelerated, Precision-enabled TMS Register hereopens in new tab/window

Monday, 22 Feb 2027 7:30–8:30 a.m.

Sigmastim

ECT Barriers to Treatment: Why Is It Difficult for Most Patients to Access ECT? This workshop will will begin with an account from Ted Scheinman, the Senior Editor of Smithsonian Magazine, and the author of the new book, Jolt, a riveting account of depression, memory and ECT. His story will be followed up by four international ECT clinicians, who will discuss the barriers to treatment in their own countries: USA, Canada, Australia and Ireland. A light breakfast will be served. Register here opens in new tab/window

Monday, 22 Feb 2027 7:30–8:30 a.m.

Vielight

Personalized Brain Intervention: Live Demonstration of the First Wearable, EEG-Guided Closed-Loop Photobiomodulation System Non-invasive brain stimulation has moved steadily toward brain-state-dependent, closed-loop delivery, yet practical implementations outside the laboratory have remained elusive. In this workshop, Vielight presents a live demonstration of a wearable, operator-free system that measures an individual's EEG in real time and automatically re-selects photobiomodulation parameters — pulse frequency, wavelength, power density, and transcranial-intranasal delivery distribution — in a continuous adaptive loop, with the participant's brain activity displayed onscreen throughout. Because light introduces no electrical artifact into concurrent EEG, measurement continues during stimulation rather than between stimulation epochs. To our knowledge, this is the first non-invasive brain stimulation system in which measurement and stimulation run concurrently and parameters adapt continuously to the individual — outside the laboratory, without an operator. The session covers the system architecture, proposed operational criteria for this class of intervention, independent research directions, and open questions, followed by audience Q&A. A light breakfast will be served. The system is an investigational research platform; no claim of clinical efficacy is made. Research access for independent groups is available, followed by clinical and consumer-grade wellness models in 2027. Speakers: Dr. Lew Lim (Founder & CEO, Vielight Inc.; inventor of the underlying patented method), Dr. Reza Zomorrodi (Advisor, Vielight Inc.; Senior Scientist, CAMH/University of Toronto), and Dr. Sorenza Bastiaens (Manager, AI & Neurotechnology, Vielight Inc.).

Tuesday, 23 Feb 2027 7:30–8:30 a.m.

MagVenture

Future of Convulsive Therapy — MST (MagVenture NEURON™ Therapy) Register hereopens in new tab/window

Tuesday, 23 Feb 2027 7:30–8:30 a.m

LivaNova

Implementing VNS Therapy for Difficult-to-Treat Depression in Clinical Practice — Practical Experience and Best Practice This clinical workshop explores the practical implementation of implantable Vagus Nerve Stimulation (VNS) Therapy for patients with difficult‑to‑treat depression. Drawing on expert consensus statements and real‑world clinical experience and the latest data from the RECOVER randomised control trial, the session will address patient selection, treatment pathways and long‑term management. Best‑practice recommendations will be discussed, alongside case examples illustrating common challenges and solutions, to support clinicians in safely and effectively integrating VNS Therapy into routine clinical practice. Register hereopens in new tab/window

Wednesday, 24 Feb 2027 7:30–8:30 a.m.

STORZ MEDICAL

Transcranial Pulse Stimulation (TPS) for Non-Invasive Brain Stimulation: Latest Advances and Future Directions Transcranial Pulse Stimulation (TPS) is an innovative treatment for patients with Alzheimer’s dementia, utilizing low-energy acoustic pulse waves to target affected brain regions. The NEUROLITH device, CE-approved since 2018, is designed for TPS treatment and delivers energy non-invasively, reaching depths of up to 8 centimetres. A standard TPS treatment protocol involves six sessions within two weeks, with each session lasting approximately 30 minutes. Follow-up sessions are tailored individually, typically scheduled 4 to 8 weeks after the initial treatment series. The TPS application is visually monitored, enabling real-time tracking of targeted brain areas, ensuring accuracy and safety. Learn moreopens in new tab/window Register hereopens in new tab/window

Ulf Ziemann & John Rothwell

Hands on TMS Physiology

Zelma Kiss

Hot topics and controversies in DBS

Dorothy Jenkins

Important Issues with taVNS

Paul Fitzgerald

Clinical applications of rTMS

Harold Sackheim

ECT

Giuseppina Pilloni

Home based neuromodulation

Mark George

Advances in implanted VNS